Megan has over 10 years of experience across healthcare including clinical medicine, research, management consulting and drug development.  She received a BA, magna cum laude, from the University of Pennsylvania in neuroscience, chemistry and music.  She completed her MD and PhD degrees at New York University with a PhD in neuroimaging and MRI physics, and was elected to Alpha Omega Alpha Honor Medical Society. Megan trained as a radiologist at NYU Langone Medical Center and previously held roles at McKinsey & Co. in the firm’s healthcare practice, Regenxbio, a gene therapy company and BridgeBio, a genetic disease company.  Megan is currently the CEO of Epitor Therapeutics (epigenetic editing) and HitchBio (red blood cell drug delivery).